Several options are available for treatment which may be used together. Always consult a licensed medical doctor.
These organizations have licensed doctors that use various repurposed drug protocols. They generally will prescribe some medications (such as hydroxychloroquine and ivermectin).
- Dr. Stella Emmanuel MD
- Budesonide Works
- FLCCC Alliance
- COVID Long Haulers – test and treatment
Efficacy of Different Treatments
Note: these do not indicate efficacy when different treatments are combined. The earlier the treatment, the higher the probability of success. Repurposed drugs must be used in combination at specific concentrations and schedules.
- Chronic Long Haulers – runs tests that check for inflammation and spike protein presence
- S1 Immune Subset Panel – With the immune subset panel test, we can measure S1 spike proteins in monocytes, detect any abnormal elevations in CD16+ monocytes
- Cytokine 14 Marker Panel – This assay gives you the results for 14 cytokines our research and publications have suggested as playing a role in inflammation.
- D-Dimer test – this test checks for micro-blood clots
Therapeutic Repurposed Drugs
This is the re-use of existing safe drugs against COVID-19. Drugs such as inhaled steroids and Ivermectin have had incredible treatment success. These are part of a protocol that has to be followed carefully in order to get the desired result. These protocols may be used in combination with other treatments such as Monoclonal Antibodies. The efficacy rates of combining various treatments together has excellent results.
You can see success rates of various treatments here. While each treatment is effective in isolation, when combined with others, treatment success rates can approach high 90%’s.
This is not a new technology and is currently manufactured by pharmaceutical companies. They are like the natural antibodies produced by your body. These have been shown to be very effective, particularly when used with repurposed drugs.
- These are currently being rationed by the Biden administration although there is no shortage of supply.
Is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. Remdesivir was approved or authorized for emergency use to treat COVID‑19 in around 50 countries. Updated guidelines from the World Health Organization in November 2020 include a conditional recommendation against the use of remdesivir for the treatment of COVID-19.
- Remdesivir has significant side effects.
- Remdesivir is not very effective.
Vaccines are not a treatment for an active infection. They are for prevention. Vaccines do not protect you from infection nor do they prevent spread. In order for a vaccine to “work”, you have to get sick, which means that you have an immune response. The best vaccine outcome is preventing death and serious injury.
- The vaccines causes death in significantly higher numbers compared to all other vaccines.
- The vaccines too often result in severe injuries (e.g. Bell’s Palsy, myocarditis, Guillaine Barre Syndrome, strokes, etc.)
2% Povidone Iodine
Mix 10% Povidone Iodine with Distilled Water to get to 2%. Apply deeply into the nose using a nasal irrigator so that it goes out the roof of the mouth. Do not swallow. Tingling should stop soon afterwards. Repeat 2-3 times per day. Use a baby nasal wash injector / irrigator to get solution into the nasal passage.
Reference: Dr. Peter McCullough
Nicotine PatchNote: this is emerging science.
- Source: Dr. Bryan Ardis (Dallas, TX) [ArdisLabs LLC]
- 7mg (smallest amount) nicotine patch for 6 days.
- Recommended brand = Rugby (or Lucy) brand from Amazon [myMedicalFreedom.org is not endorsing these nor receiving any form of compensation]
- Nicotine gum may also help.
- Need to find January 2023 study referenced in video.
- Study: https://classic.clinicaltrials.gov/ct2/show/NCT04583410
- Nicotine Patch, Lozenge or Gum During COVID-19 Hospitalization may Reduce Mortality for Those Who Smoke
- Study: A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications
- Study: Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19
- Study: What is the impact of nicotine on the Post-COVID-19 syndrome – a severe impairment of acetylcholineorchestrated neuromodulation: A case series
- Study: Nicotine exposure decreases likelihood of SARS-CoV-2 RNA expression and neuropathology in the hACE2 mouse brain but not moribundity (Nature)
- Study: Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain–in vitro and ex vivo evidence
- Study: Nicotine Attenuates Disruption of Blood–Brain Barrier Induced by Saturated-Fat Feeding in Wild-Type Mice
- Study: Nicotine exposure alters in vivo human responses to endotoxin